Newly released documents outline Indiana’s proposal to toll I-70, with drivers potentially paying about 10 cents per mile if federal officials approve the plan.

Company outlines obedience, puppy, private lesson, in-home, behavior-focused, and board-and-train programs for dogs in ...

The IRS and Treasury proposed new rules for Trump Accounts, including details for opening an account and taking the federal seed money if eligible to do so.

Greyhound represents a highly prospective, silver-gold opportunity with the benefit of existing infrastructure and a historic mine site, while offering significant upside through exploration and ...

School District 57’s Indigenous education department is using technology and spins on familiar materials to help teach students about languages and cultures, the board of education heard at its ...

PORTLAND, Ore. — Oregon Treasurer Elizabeth Steiner was a guest on this week's episode of Straight Talk to discuss how Oregonians can check for any unclaimed money that they might be owed by the state ...

Add Yahoo as a preferred source to see more of our stories on Google. London's Mayor Josh Morgan was at RBC Place on Wednesday to deliver his fourth annual state of the city address. (Isha ...

CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted ...

SIOUX CITY (KTIV) - The Sioux City City Council met with department heads Friday Jan. 17 morning to outline the 2027 Fiscal Year budget for the Capital Improvement Program. The process has the council ...

Five-time major winner Brooks Koepka will be back on the PGA Tour sooner than expected after a Returning Member Program was revealed Monday. Koepka announced last month he would part ways with LIV ...

Ahead of CTE Month, BIN95 highlights how automation and maintenance training prepare students for tomorrow’s workforce. Career and Technical Education prepares students for real-world success,” said a ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases ...